An Observational Multi-cohort Study on the Use of Fosamprenavir-Ritonavir Among HIV-infected Children and Adolescents in Europe.

Trial Profile

An Observational Multi-cohort Study on the Use of Fosamprenavir-Ritonavir Among HIV-infected Children and Adolescents in Europe.

Completed
Phase of Trial: Phase IV

Latest Information Update: 05 Jun 2017

At a glance

  • Drugs Fosamprenavir; Ritonavir
  • Indications HIV-1 infections
  • Focus Adverse reactions
  • Acronyms PENTA Fosamprenavir
  • Sponsors ViiV Healthcare
  • Most Recent Events

    • 08 Feb 2012 Company (ViiV Healthcare) added as trial sponsor and additional lead trial centre identified as reported by ClinicalTrials.gov.
    • 03 Feb 2012 Additional location (United Kingdom) added and additional trial acronym (PENTA Fosamprenavir) identified as reported by ClinicalTrials.gov.
    • 03 Feb 2012 Actual patient number (1) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top